US OptionsDetailed Quotes
HOOK250117P10000
- 0.00
- 0.000.00%
15min DelayClose Jan 17 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover0.00%IV-412.82%PremiumJan 17, 2025Expiry Date8.05Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.24Leverage Ratio--Theta--Rho--Eff Leverage--Vega
HOOKIPA Pharma Stock Discussion
Sign in to post a comment
$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma and HOOKIPA Pharma have provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer is m...
Poolbeg Pharma and HOOKIPA Pharma have provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer is m...
1
$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharmahave provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer ...
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharmahave provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer ...
2
$HOOKIPA Pharma (HOOK.US)$ to weak..?
$HOOKIPA Pharma (HOOK.US)$ no pre market?
$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharma have announced important updates regarding their potential combination. Gilead Sciences, a significant HOOKIPA shareholder owning 19.4% (1,875,947 shares) of HOOKIPA's issued share capital, has indicated its intention to vote in line with HOOKIPA Board's recommendation for a formal offer and participate in the ...
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharma have announced important updates regarding their potential combination. Gilead Sciences, a significant HOOKIPA shareholder owning 19.4% (1,875,947 shares) of HOOKIPA's issued share capital, has indicated its intention to vote in line with HOOKIPA Board's recommendation for a formal offer and participate in the ...
1
3
$HOOKIPA Pharma (HOOK.US)$ top rocket?
$HOOKIPA Pharma (HOOK.US)$ Stocktitan.net
M&A Expert:positive
This amendment to HOOKIPA's Rule 2.4 announcement reveals critical details about a potential business combination with Poolbeg Pharma plc. The correction of HOOKIPA's ISIN code (US43906K2096) reflects their July 2024 1-for-10 reverse stock split. The company's current capital structure includes 9,655,022 common shares, 2,399,517 Class A common shares and various ser...
M&A Expert:positive
This amendment to HOOKIPA's Rule 2.4 announcement reveals critical details about a potential business combination with Poolbeg Pharma plc. The correction of HOOKIPA's ISIN code (US43906K2096) reflects their July 2024 1-for-10 reverse stock split. The company's current capital structure includes 9,655,022 common shares, 2,399,517 Class A common shares and various ser...
1
1
$American Battery Technology (ABAT.US)$ Hoping for a head and shoulders pattern to show up. I'm not saying it will, but to me it looks like it has all the markings too. I really got in because of the huge amount of volume it got before the new year.
$Draganfly (DPRO.US)$ i think this will get back into the trend it was ...
$Draganfly (DPRO.US)$ i think this will get back into the trend it was ...
+2
30
19
9
$HOOKIPA Pharma (HOOK.US)$ i tough better buy now. i see target price is $7.
1
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
How to see through the futureNo comment yet
GingleCash OP : I’m in!Got me some more!
GingleCash OP : Get some!more!
103851773 : awesome
Clayborne : shorting?
GingleCash OP : Negative-I’m a never shorter! looking for after hours bounce!